Novo Nordisk A/SNVONYSE
Loading
Total revenue from sales of goods and services
3Y CAGR
+18.9%/yr
vs +12.2%/yr prior
5Y CAGR
+18.5%/yr
Consistent
Acceleration
+6.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $297.20B | +2.3% |
| 2024 | $290.40B | +25.0% |
| 2023 | $232.26B | +31.3% |
| 2022 | $176.95B | +25.7% |
| 2021 | $140.80B | +10.9% |
| 2020 | $126.95B | +4.0% |
| 2019 | $122.02B | +9.1% |
| 2018 | $111.83B | +0.1% |
| 2017 | $111.70B | -0.1% |
| 2016 | $111.78B | - |